A groundbreaking study suggests that if we could eliminate aging mechanisms, humans could potentially live between 146 to 194 years. Researchers spotlight somatic mutations as key contributors to ...

A new review argues that induced mutagenesis, integrated with genomics and high-throughput phenotyping, could overcome the ...

A barcoded shuttle-vector sequencing assay shows that chronic low-dose gamma irradiation amplifies pre-existing mutation ...

Viruses, cells and cancer challenge one of biology’s simplest questions: what exactly makes something alive? Examining these systems reveals why the boundary between living and nonliving may be ...

Repetitive sequences make extrachromosomal DNA vulnerable to breaks, which could be exploited for therapy — but might also promote tumour evolution.

The Endless Arms Race Between Pathogens and HumansEvery time I see news about infectious diseases, I think about this.Could ...

Introduction How much of scientific research can AI handle? This question is no longer just about discussing future ...

Investors Should Know: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma ...

If you would like to arrange a 1on1 meeting with Aprea management during the conference, please contact your Maxim representative. For more information and a complete agenda, please refer to ...

Mammalian biology unfolds over time, within tissues and organs opaque to our eyes and instruments. We applied DNA Typewriter, ...

Cancer genetics is the study in humans and other animals of heritable gene variants that cause or confer altered risk of tumour or hematological malignancy. Individual cancer risk varies and is ...

Roche announced US FDA approval of Tecentriq and Tecentriq Hybreza in combination with fluoropyrimidine- and oxaliplatin-based chemotherapy for ...